Glenmark Pharmaceuticals launches nicotine gum Kwitz

New Delhi: Glenmark Pharmaceuticals said it has launched nicotine replacement therapy product Kwitz that helps smokers quit smoking.

Kwitz nicotine gum will be available in two variants of 2 mg as an OTC product 4mg as a prescription product, the company said in a statement.

While Kwitz 2 mg is for those smoking less than 20 cigarettes per day, Kwitz 4 mg is meant for smokers consuming more than 20 cigarettes per day, it added.

Glenmark Pharmaceuticals President and Head India, Middle-East and Africa, Sujesh Vasudevan said Kwitz is aimed at helping individuals find a sustainable way to stop smoking in an easy step-by-step process.